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ABSTRACT 
When orthodontic forces are applied to a tooth, they are transmitted to the 
periodontal ligament (PDL) and adjacent alveolar bone.  
 
These forces, in turn, initiate a complex cascade of events that result in the 
remodeling of the surrounding bone and eventual movement of the tooth
2
.  
 
While the sequence of events at the tissue and cellular levels of bone 
remodeling is well described, there remains a lack of comprehensive understanding in 
the coordination of biochemical events at the molecular level. 
 
While there are numerous interconnected systems in place that control the 
levels of mature osteoclasts and osteoblasts active during bone remodeling, one 
predominate pathway uses the cytokine family interleukin -10 ( IL -10) as a signal 
transducer . 
 
Most importantly, IL - 10 plays a critical role in the differentiation of both 
osteoclasts and osteoblasts. Osteoclasts are derived from hematopoietic precursors in 
the bone marrow, whereas osteoblasts are mesenchymal in origin
5
. 
 
Regardless of the cell’s origin, however, IL-10 type cytokines stimulate the 
differentiation of the respective precursors into osteoblasts and osteoclasts. 
 
Thus the aim of the study was to evaluate the level of INTERLEUKIN – 10 in 
GINGIVAL CEVICULAR FLUID (GCF) during orthodontic tooth movement with 
the methodology of assessment using ELISA technique. 
 
Key-words : Bone remodelling, Interleukin – 10, GCF, ELISA technique 
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INTRODUCTION 
 
Mechanotransduction  induced by orthodontic force occurs when external 
strain induces mechanosensing (the cell senses structural changes in the 
extracellular matrix, caused by external mechanical loading), transduction and 
cellular response in several paradental tissues.This process leads to vasculature 
and extracellular matrix remodeling in the periodontal ligament (PDL), gingiva, 
and alveolar bone.This remodeling is facilitated by proliferation,differentiation, 
and apoptosis of local periodontal cells, bone cell precursors, and leukocyte 
migration from the microvascular compartment.,An understanding of bone 
remodeling is of  particular interest to the profession of orthodontics. 
 
Unperturbed, the native pattern of alveolar bone remodeling maintains a 
homeostatic state.  
 
The introduction of orthodontic treatment, however, disrupts the 
equilibrium between bone apposition and bone resorption 
103
. 
 
When orthodontic forces are applied to a tooth, they are transmitted to the 
periodontal ligament (PDL) and adjacent alveolar bone.  
 
These forces, in turn, initiate a complex cascade of events that result in the 
remodeling of the surrounding bone and eventual movement of the tooth
104
 .  
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While the sequence of events at the tissue and cellular levels of bone 
remodeling is well described, there remains a lack of comprehensive 
understanding in the coordination of biochemical events at the molecular level 
105
. 
As such, there  have been numerous studies that have sought to further elucidate 
the molecular biology of  bone remodeling during orthodontic tooth movement. 
 
In order to examine the molecular biology involved, a cellular 
understanding of tooth movement is prerequisite. Osteoclasts are the primary bone 
resorbing cells in the body, whereas osteoblasts are the primary bone forming 
cells. A large number of osteoclasts are recruited to the resorptive front during 
tooth movement 
106
. As the tooth begins to move into the resorbed area, 
osteoblasts proliferate and begin to secrete the precursors of new bone in the 
vacated area 
107,108
. 
  
Cycling between osteoclast and osteoblast activity, the body must maintain 
a type of equilibrium in order to obtain efficient bone remodelling during tooth 
movement. 
 
While there are numerous interconnected systems in place that control the 
levels of mature osteoclasts and osteoblasts active during bone remodeling, one 
predominate pathway uses the cytokine family interleukin -10 ( IL -10) as a signal 
transducer . 
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Most importantly, IL - 10 plays a critical role in the signalling mechanism 
of both osteoclasts and osteoblasts. Osteoclasts are derived from hematopoietic 
precursors in the bone marrow, whereas osteoblasts are mesenchymal in origin.
109 
 
IL-10  also  interacts with other  factors that are critically involved with 
bone homeostasis, including the receptor activator of nuclear factor kappa-β 
(RANK)/receptor activator of nuclear factor kappa-β ligand (RANKL)/ 
osteoprotegerin (OPG) system, sex steroids, prostaglandin E2 (PGE2), tumor 
necrosis factor (TNF)-α, parathyroid hormone (PTH), IL- 11, and IL-1b. 
 
While IL 4,6,8 has been extensively studied in other models of bone 
metabolism, the investigation of the role of  IL -10 during orthodontic tooth 
movement is relatively limited. 
 
The gingival crevicular fluid (GCF) is an osmotically mediated 
inflammatory exudates found in the gingival sulcus. As an exudate,it tends to 
increase in volume with inflammation and capillary permeability.
110 
 
Serum is the primary source of the aqueous component of the GCF. 
However, the gingival tissue through which the fluid passes, along with bacteria 
both in tissues and the gingival crevice, can modify its composition. Therefore, its 
constituent vary according to the condition of the periodontal tissues. In general, 
cells, immunoglobulins, microorganisms, toxins, and lysosomal enzymes can all 
be detected in the GCF.
116 
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The released molecules evoke cellular responses in the various cell types 
in and around teeth, providing a favourable microenvironment for tissue 
deposition or resorption. 
 
Various cell-signalling pathways are activated, which ultimately stimulate 
PDL turnover, as well as localised bone resorption and bone deposition. 
 
Additionally, since tooth movement is a reliable model of overall bone 
metabolism, the results of this study will aid in more clearly understanding 
somatic bone remodeling and repair. 
 
Furthermore, orthodontic tooth movement and periodontal disease involve 
similar factors, and knowledge of the cytokines involved in both processes may 
lead to an increased comprehension of the complications involved with tooth 
movement such as loss of attachment and external apical root resorption. Lastly, 
future research may provide the clinician with novel techniques that make use of 
the complex role of IL-10 in orthodontic tooth movement. A convenient and non-
invasive method to study molecules involved with tooth movement is gingival 
crevicular fluid (GCF) analysis. Using this approach, the presence of many 
inflammatory factors has been identified, and the role these factors play in 
orthodontic tooth movement has become more clearly understood. 
 
Previously bone resorptive markers were studied extensively using the gcf 
samples from rats. 
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Other forms of bone remodelling studies have been studied using cone 
beam computed tomography ( cbct) ,but the drawbacks in those study were the 
radiation dosage was a factor of concern to the orthodontic profession
114
 . so a 
non-invasive methodology to study bone remodelling in patients have to be 
studied in this regard so the gcf study was undertaken. 
 
Although studies have been done in the past using different markers ,very 
few studies have been done using IL – 10 marker. So the present study was done 
to quantify bone remodelling based on IL – 10. 
 
Prior to this study many studies based on orthodontic tooth movement 
evaluation using gcf was carried out in subjects who were in retraction stage or 
end of retraction stage .In those studies bone remodelling was identified with 
elevation of the pro-inflammatory and anti –inflammatory markers.  
 
In this study we are assessing bone remodelling at the end of levelling and 
alignment stage itself by quantifying the elevation of IL – 10 marker between the 
two time points T0 and T1and between upper and lower arches which is unique to 
this study. 
 
Thus the aim of this study was to evaluate the effects of orthodontic tooth 
movement on the levels of interleukin 10 in GCF. 
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REVIEW OF LITERATURE 
 
Reitan (1951)
1
 stated that the first stage occurs when tooth movement is initiated 
by the increased mechanical loading of an orthodontic force. The initial 
movement of the tooth within the periodontal ligament space results in a positive 
strain on the bone apposition side  of the periodontal ligament. The side opposite 
of the appositional side, on the other hand, undergoes a negative strain within the 
periodontal ligament, and is commonly referred to as the pressure side. 
 
Midgett et al (1981)
2
 stated that the periodontal ligament is compressed on the 
side opposite of the force causing an increase in pressure, whereas the periodontal 
ligament on the same side of the force increases in tension . The changes in 
pressure and tension within the periodontal ligament space initiate cellular 
changes produced by chemical messengers. 
  
On the pressure side, there is a decrease in cellular replication as a result of 
vascular constriction, whereas on the tension side, there is an increase in cellular 
replication because of the stimulation afforded by the stretching of the fiber 
bundles of the periodontal ligament. 
 
Rygh et al ( 1986 )
3
 stated that the side of bone apposition is often referred to as 
the tension side in the pressure-tension theory but may be more accurately 
described as the appositional side. This positive strain creates a stretching of the 
collagen fibers connecting the tooth to the bone, which in turn, can activate 
residing periodontal cells such as osteoblasts and fibroblasts. 
 
Review of Literature   
 
 
 7 
Davidovitch et al (1988)
4
 stated that pathways stimulate the production of 
mediators such as interleukins, nitric oxide, and prostaglandins that activate 
several types of cells. 
 
Davidovitch (1991)
5
 stated that cell strain is the next step in the response to  
orthodontic tooth movement. 
 
Hynes (1992 )
6
 also acknowledged   that cell strain is the next step in the response 
to orthodontic tooth movement. 
 
Weinbaum et al (1994)
7
 stated that the fluid flow on both the appositional and 
resorptive sides may activate entrapped osteocytes within the bone through 
canaliculi. 
 
Cowin et al (1995)
8
 stated that the fluid flow on both the appositional and 
resorptive sides may activate entrapped osteocytes within the bone through 
canaliculi. 
 
Klein-Nulend et al (1995)
9
 also stated that pathways stimulate the production of 
mediators such as interleukins, nitric oxide, and prostaglandins that activate 
several types of cells. 
 
Klein-Nulend et al (1995)
10
 also found that this concept is often referred to as 
fluid shear stress theory and is supported by both in vitro data. 
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Pitsillides et al (1995)
11
 also stated that this concept is often referred to as fluid 
shear stress theory and is supported  by both in vivo data. 
 
Turner et al (1995)
12 also stated that this concept is often referred to as fluid 
shear stress theory and is supported  by both in vivo data. 
 
Ajubi et al (1996)
13
 also stated that this concept is often referred to as fluid shear 
stress theory and is supported by both in vitro data.  
 
Beertsen et al (1997)
14
 stated that collagen fiber tension and fluid flow cause 
deformation of periodontal ligament cells through a network of cell-matrix 
attachments . These cells include both fibroblasts and osteoblasts. 
 
Mak et al (1997)
15
 stated that the fluid flow on both the appositional and 
resorptive sides may activate entrapped osteocytes within the bone through 
canaliculi. 
 
Owan et al (1997)
16
 also stated that this concept is often referred to as fluid shear 
stress theory and is supported by both in vitro data. He also stated that cytokines 
likely stimulate the production and differentiation of osteoblasts which are the 
primary cells associated with bone deposition. While not the focus of this review, 
it is important to note that the degradation and production of extracellular matrix 
material also plays an important role in orthodontic tooth movement. The 
periodontal fibroblasts react in a similar way as osteoblasts in that they react to a 
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number of mediators, including prostaglandins, MMPs, cathepsins, interleukin-1 
beta, and transforming growth factor-β. 
 
Teitelbaum et al (1997)
17
 stated that It is at this site that hydrogen ions are 
released to dissolve  the bone, and enzymes resorb residual organic matrix.  
 
Hill (1998)
18
 stated that the clear zone isolates the bone surface; the body of the 
osteoclast contains an extensive lysosomal system; and the ruffled border is the 
site of actual bone resorption. 
 
Matsuda et al (1998)
19
 stated that as the bone undergoes resorption, space is 
created to allow movement in the direction of force application. The appositional 
side, meanwhile, is undergoing bone formation that is mediated by the production 
of alkaline phosphatase, osteocalcin, and other non-collagenous proteins .  
 
Howard et al (1998)
20
 also stated that cytokines likely stimulate the production 
and differentiation of osteoblasts which are the primary cells associated with bone 
deposition. While not the focus of this review, it is important to note that the 
degradation and production of extracellular matrix material also plays an 
important role in orthodontic tooth movement. The periodontal  fibroblasts react 
in a similar way as osteoblasts in that they react to a number of mediators, 
including prostaglandins, MMPs, cathepsins, interleukin-1 beta, and transforming 
growth factor-β 
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Melsen (1999)
21
 also stated that the side of bone apposition is often referred to as 
the tension side in the pressure-tension theory but may be more accurately 
described as the appositional side. This positive strain creates a stretching of the 
collagen fibers connecting the tooth to the bone which in turn, can activate 
residing periodontal cells such as osteoblasts and fibroblasts. This term, however, 
can be somewhat misleading as the collagen fibers on this side actually relax upon 
force application due to the negative strain. 
  
Westbroek et al(2000)
22
 also stated that pathways stimulate the production of 
mediators such as interleukins, nitric oxide, and prostaglandins that activate 
several types of cells. He also stated that this concept is often referred to as fluid 
shear stress theory  and is supported by both in vitro data. 
 
Knothe Tate et al (2000)
23
 also stated that this concept is often referred to as fluid 
shear stress theory and is supported  by both in vivo data. 
 
Nomura and Takano-Yamamoto (2000)
24
 found that these osteoclast associated 
regulating cytokines have been shown in vitro and in vivo to include colony-
stimulating factor, receptor activator of nuclear factor kappa β ligand (RANKL), 
osteoprotegerin (OPG), and bone morphogenic proteins.  
 
Gay and Weber (2000)
25
 stated that after osteoclast differentiation has begun, the 
osteoclasts are stimulated by osteoblast and osteocyte released osteopontin to 
begin attaching to the bone surface by specific integrins.  
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You et al (2000)
26
 also stated that cytokines likely stimulate the production and 
differentiation of osteoblasts which are the primary cells associated with bone 
deposition.  While not the focus of this review, it is important to note that the 
degradation and production of extracellular matrix material also plays an 
important role in orthodontic tooth movement. The periodontal  fibroblasts react 
in a similar way as osteoblasts in that they react to a number of mediators, 
including prostaglandins, MMPs, cathepsins, interleukin-1 beta, and transforming 
growth factor-β. 
 
Alhashimi et al (2001)
27
 also stated that pathways stimulate the production of 
mediators such as interleukins, nitric oxide, and prostaglandins that activate 
several types of cells. 
 
Shiotani et al (2001)
28
 stated that these osteoclast associated regulating cytokines 
have been shown in vitro and in vivo to include colony-stimulating factor, receptor 
activator of nuclear factor kappa β ligand (RANKL), osteoprotegerin (OPG), and 
bone morphogenic proteins. 
 
Binderman et al (2002)
29
 also stated that this term, however, can be somewhat 
misleading as the collagen fibers on this side actually relax upon force application 
due to the negative strain. 
 
Zhao et al (2002)
30
 stated that these osteoclast associated regulating cytokines 
have been shown in vitro and in vivo to include colony-stimulating factor, receptor 
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activator of nuclear factor kappa β ligand (RANKL), osteoprotegerin (OPG), and 
bone morphogenic proteins. 
 
Bakker et al (2003)
31
 also stated that pathways stimulate the production of 
mediators such as interleukins, nitric oxide, and prostaglandins that activate 
several types of cells. 
 
Apajalahti et al., (2003)
32
 also stated that cytokines likely stimulate the 
production and differentiation of osteoblasts which are the primary cells 
associated with bone deposition. While not the focus of this review, it is important 
to note that the degradation and production of extracellular matrix material also 
plays an important role in orthodontic tooth movement. The periodontal  
fibroblasts react in a similar way as osteoblasts in that they react to a number of 
mediators, including prostaglandins, MMPs, cathepsins, interleukin-1 beta, and 
transforming growth factor-β. 
 
Takahashi et al (2003)
33
  also stated that cytokines likely stimulate the production 
and differentiation of osteoblasts which are the primary cells associated with bone 
deposition. While not the focus of this review, it is important to note that the 
degradation and production of extracellular matrix material also plays an 
important role in orthodontic tooth movement. The periodontal  fibroblasts react 
in a similar way as osteoblasts in that they react to a number of mediators, 
including prostaglandins, MMPs, cathepsins, interleukin-1 beta, and transforming 
growth factor-β. 
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Mullender et al (2004)
34
 also stated that pathways stimulate the production of 
mediators such as interleukins, nitric oxide, and prostaglandins that activate 
several types of cells. 
 
Yoo et al (2004)
35
 in his study found that osteocytes release cytokines, which 
stimulate the differentiation of precursors into osteoclasts on the resorptive side. 
 
Phan et al (2004)
36
 stated that It is at this site that hydrogen ions are released to 
dissolve the bone, and enzymes resorb residual organic matrix. 
 
Nahm et al (2004)
37
 also stated that cytokines likely stimulate the production and   
differentiation of osteoblasts which are the primary cells associated with bone 
deposition. While not the focus of this review, it is important to note that the 
degradation and production of extracellular matrix material also plays an 
important role in orthodontic tooth movement. The periodontal  fibroblasts react 
in a similar way as osteoblasts in that they react to a number of mediators, 
including prostaglandins, MMPs, cathepsins, interleukin-1 beta, and transforming 
growth factor-β. 
 
Yamaguchi et al (2004)
38
 also stated that cytokines likely stimulate the 
production and differentiation of osteoblasts which are the primary cells 
associated with bone deposition. While not the focus of this review, it is important 
to note that the degradation and production of extracellular matrix material also 
plays an important role in orthodontic tooth movement. The periodontal  
fibroblasts react in a similar way as osteoblasts in that they react to a number of 
 
Review of Literature   
 
 
 14 
mediators, including prostaglandins, MMPs, cathepsins, interleukin-1 beta, and 
transforming growth factor-β. 
 
Ozaki et al (2005)
39
 stated that as the bone undergoes resorption, space is created 
to allow movement in the direction of force application. The appositional side, 
meanwhile, is undergoing bone formation that is mediated by the production of 
alkaline phosphatase, osteocalcin, and other non-collagenous proteins .  
 
Ingman et al (2005)
40
   also stated that cytokines likely stimulate the production 
and differentiation of osteoblasts which are the primary cells associated with bone 
deposition. While not the focus of this review, it is important to note that the 
degradation and production of extracellular matrix material also plays an 
important role in orthodontic tooth movement. The periodontal  fibroblasts react 
in a similar way as osteoblasts in that they react to a number of mediators, 
including prostaglandins, MMPs, cathepsins, interleukin-1 beta, and transforming 
growth factor-β. 
 
Tang et al (2006)
41
 also stated that pathways stimulate the production of 
mediators such as interleukins, nitric oxide, and prostaglandins that activate 
several types of cells. 
 
Tan et al (2006)
42
 also stated that this concept is often referred to as fluid shear 
stress theory and is supported by both in vitro data. 
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Wang and Thampatty (2006)
42
 stated that this strain is then transferred within 
the cell by the  focal adhesion complex to the cytoskeleton and protein kinases 
that initiate intracellular signaling pathways. 
 
Kurata et al (2006)
43
 stated that these osteoclast associated regulating cytokines 
have been shown in vitro and in vivo to include colony-stimulating factor, receptor 
activator of nuclear factor kappa β ligand (RANKL), osteoprotegerin (OPG), and 
bone morphogenic proteins. 
 
Yang et al (2006)
44
 stated that as the bone undergoes resorption, space is created 
to allow movement in the direction of force application. The appositional side, 
meanwhile, is undergoing bone formation that is mediated by the production of 
alkaline phosphatase, osteocalcin, and other non-collagenous proteins .  
 
Takahashi et al (2006)
45
 also stated that cytokines likely stimulate the production 
and differentiation of osteoblasts which are the primary cells associated with bone 
deposition. While not the focus of this review, it is important to note that the 
degradation and production of extracellular matrix material also plays an 
important role in orthodontic tooth movement. The periodontal  fibroblasts react 
in a similar way as osteoblasts in that they react to a number of mediators, 
including prostaglandins, MMPs, cathepsins, interleukin-1 beta, and transforming 
growth factor-β. 
 
Henneman (2008)
46
 stated that therefore, it may be more accurately referred to as 
the resorptive side. As negative strain occurs on the resorptive side, the fluid 
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within the periodontal ligament space undergoes an almost immediate fluid flow. 
The last two stages occur simultaneously and in conjunction with one another. 
The mediators released by the activated periodontal cells stimulate osteocytes and 
a variety of periodontal ligament cells including osteoblasts, fibroblasts, and 
osteoclast-precursors. 
 
Molecular Level of Tooth Movement 
 
Simpson et al (1997)
47
in his study stated that Cytokines are often described as 
pleiotropic due to the variety of  effects they can stimulate depending on the 
nature of the target cell Some cytokines may  elicit agonistic or antagonistic 
effects on the same target cell depending on the surrounding factors. In addition to 
the pleiotropism that they may exhibit, cytokines often display overlapping 
biological activities and may even share the same receptors . 
 
Simonet et al (1997)
48
 stated that a system of cytokines of particular significance 
in understanding the relationship between osteoclastogenesis and 
osteoblastogenesis in tooth movement is the OPG/RANKL/RANK system. The 
discovery of osteoprotegerin was the first step in understanding this complex 
interaction. The molecule was discovered independently by two groups 
conducting contrasting experiments. While studying therapeutic utilities of TNF 
receptor-related molecules, the Amgen, Inc. group stumbled upon a relatively 
innocuous protein whose overexpression caused marked osteopetrosis in rats. 
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Yasuda et al (1998)
49
 stated that It was found that this was due to a decrease in 
osteoclasts, indicating that OPG played a clear role in regulating 
osteoclastogenesis. The Snow Brand Milk Group, meanwhile, was systematically 
searching for a theoretical molecule fulfilling the role that OPG occupies now 
when they discovered the same protein as the Amgen, Inc. group  
 
Heinrich et al (1998)
50
 stated that as in most biological functions, cytokines are 
the soluble factors primarily involved in the coordinate activities of osteogenic 
cells. While typically only present in nanomolar-to-picomolar concentrations , 
cytokines regulate the proliferative, differentiative, and maturation events in most 
cells throughout the body. Unlike hormones, which are stored for later secretion, 
cytokines are usually rapidly synthesized locally and then immediately secreted 
when stimulated . When the two communicating cells are in close proximity, the 
rapidity of synthesis and secretion can make cytokine detection difficult. 
 
Khosla (2001)
51
 stated that OPG has since undergone significant research to 
further characterize the protein. 
 
RANK/RANKL/OPG System 
 
Anderson et al (1997)
52
 stated that RANK had previously been identified as the 
receptor for RANKL, so its involvement in osteoclastogenesis regulation became 
readily apparent. 
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Lacey et al (1998)
53
 stated that the discovery of OPG warranted the search for an 
osteoclast differentiation factor expressed on osteoblastic cells that was essential 
for osteoclast development. The identification of RANKL as this protein was 
quickly realized by the two previously mentioned groups. RANKL was shown to 
play a key role in osteoclast differentiation stimulation, osteoclast activity, and the 
inhibition of osteoclast apoptosis. 
 
Yasuda et al (1998)
54
 stated that the discovery of OPG warranted the search for 
an osteoclast differentiation factor expressed on osteoblastic cells that was 
essential for osteoclast development. The identification of RANKL as this protein 
was quickly realized by the two previously mentioned groups. 
 
Fuller et al (1998)
55
stated that RANKL was shown to play a key role in osteoclast 
differentiation stimulation, osteoclast activity, and the inhibition of osteoclast 
apoptosis. Nakagawa et al (1998)  If OPG is not present, however, then RANKL 
is free to bind to its natural receptor, RANK . 
 
Shalhoub V, Faust J, Boyle WJ, Dunstan CR, Kelley M, Kaufman S, Scully S, 
Van G, Lacey DL(1999)
56
 demonstrated the effects of soluble OPGL and OPG on 
the developing human osteoclast phenotype, on bone slices, using peripheral 
blood mononuclear cells (PBMCs), cultured for 2 weeks, without stromal cells. 
They found that OPGL (2-50 ng/ml), increased the size of osteoclast-like cells on 
bone, as defined by the acquisition of osteoclast markers: vitronectin receptor 
(VR), tartrate-resistant acid phosphatase (TRAP), multinuclearity, and bone 
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resorption. By 14 days, with 20 ng/ml OPGL, the largest cells/10x field had 
achieved an average diameter of 163+/-38 microm, but only approximately 10-20 
microm in its absence and the number of osteoclast-like cells/mm2 bone surface 
was about 128. By scanning electron microscopy, OPGL-treated (20-ng/ml) 
cultures contained small osteoclast-like cells on bone with ruffled "apical" 
surfaces by day 7; by day 15, large osteoclast-like cells were spread over 
resorption lacunae. At 15 ng/ml OPGL, about 37% of the bone slice area was 
found to be covered by resorption lacunae. This study confirms a pivotal role for 
OPGL and OPG in the modulation of human osteoclast differentiation and 
function. 
 
Takahashi N, Udagawa N, Suda T. (1999)
57
 showed that osteoblasts/stromal cells 
express a member of the TNF-ligand family "osteoclast differentiation 
factor(ODF)/osteoprotegerin ligand (OPGL)/TNF-related activation-induced 
cytokine (TRANCE)/receptor activator of NF-kB ligand (RANKL)" as a 
membrane associated factor. Osteoclast precursors which possess RANK, a TNF 
receptor family member, recognize ODF/OPGL/TRANCE/RANKL through cell-
to-cell interaction with osteoblasts/stromal cells, and differentiate into osteoclasts 
in the presence of macrophage colony-stimulating factor. Mature osteoclasts also 
express RANK, and their bone-resorbing activity is also induced by 
ODF/OPGL/TRANCE/RANKL which osteoblasts/stromal cells possess. 
Osteoprotegerin (OPG)/osteoclastogenesis inhibitory factor (OCIF)/TNF receptor-
like molecule 1 (TR1) is a soluble decoy receptor for 
ODF/OPGL/TRANCE/RANKL. They found that activation of  NF-kB through 
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the RANK-mediated signaling system appears to be involved in differentiation 
and activation of osteoclasts. 
 
Hailing Hsu, David Lacey, Colin r. Dunstan, Irina Solovyev, Anne Colombero, 
Emma Timms, Hong-lin Tan, Gary Elliott, Michael J. Kelley, Ildiko Sarosi, 
Ling wang, Xing-zhong Xia, Robin Elliott, Laura Chiu, Tabitha Black, Sheila 
Scully, Casey Capparelli, Sean Morony, Grant Shimamoto, Michael Bass, and 
William Boyle (1999)
58
 took the genomic approach to examine genes expressed in 
murine osteoclast precursors. They described the identification and 
characterization of the osteoclast differentiation and activation receptor that is 
present on normal mouse osteoclast progenitors and which mediates OPGL-
induced osteoclast differentiation and activation. The identified receptor is indeed 
identical to the TNFR family member RANK. Like several known TNFR family 
members, the signaling pathway of RANK involves the interaction with 
cytoplasmic TNFR-associated factor (TRAF) proteins. Cumulatively, their 
findings reveal that OPGL–RANK–OPG comprise key regulatory proteins that 
govern osteoclast development. 
 
Teresa L. Burgess, Yi-xin Qian, Stephen Kaufman, Brian D. Ring, Gwyneth 
Van, Charles Capparelli, Michael Kelley, Hailing Hsu, William J. Boyle, Colin 
R. Dunstan, Sylvia Hu, and David L. Lacey (1999)
59
 using primary cultures of rat 
osteoclasts on bone slices, found that OPGL causes approximately sevenfold 
increase in total bone surface erosion. By scanning electron microscopy, it was 
found that OPGL-treated osteoclasts generate more clusters of lacunae on bone 
suggesting that multiple, spatially associated cycles of resorption have occurred. 
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However, the size of the individual resorption events are unchanged by OPGL 
treatment. Mechanistically, OPGL binds specifically to mature OCs and rapidly 
(within 30 min) induces actin ring formation; a marked cytoskeletal rearrangement 
that necessarily precedes bone resorption. Furthermore, they also showed that 
antibodies raised against the OPGL receptor, RANK, also induce actin ring 
formation. OPGL treated mice exhibit increases in blood ionized Ca++ within 1 h 
after injections, consistent with immediate OC activation in vivo. 
 
Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT, Martin TJ. (1999)
60
 
showed that osteoclast precursors express RANK, a TNF receptor family member, 
recognize RANKL through cell-to-cell interaction with osteoblasts/stromal cells, 
and differentiate into osteoclasts in the presence of M-CSF. 
 
Kong YY, Feige U, Sarosi I, Bolon B, Tafuri A, Morony S, Capparelli C, Li J, 
Elliott R, McCabe S, Wong T, Campagnuolo G, Moran E, Bogoch ER, Van G, 
Nguyen LT, Ohashi PS, Lacey DL, Fish E, Boyle WJ, Penninger JM. (1999)
61
 
showed that bone remodelling and bone loss are controlled by a balance between 
the tumour necrosis factor family molecule osteoprotegerin ligand (OPGL) and its 
decoy receptor osteoprotegerin (OPG). They reported that activated T cells can 
directly trigger osteoclastogenesis through OPGL. Systemic activation of T cells 
in vivo leads to an OPGL-mediated increase in osteoclastogenesis and bone loss. 
They demonstrated that in a T-cell-dependent model of rat adjuvant arthritis 
characterized by severe joint inflammation, bone and cartilage destruction and 
crippling, blocking of OPGL through osteoprotegerin treatment at the onset of 
disease prevents bone and cartilage destruction but not inflammation. These 
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results show that both systemic and local T-cell activation can lead to OPGL 
production and subsequent bone loss. 
 
Malyankar et al (2000)
62
 stated that RANKL was shown to play a key role in 
osteoclast differentiation stimulation, osteoclast activity, and the inhibition of 
osteoclast apoptosis. 
 
Khosla (2001)
63
 stated that the interaction between the three proteins is actually 
quite simple. Osteoblasts produce both osteoclastogenesis-stimulating RANKL 
and osteoclastogenesis-inhibiting OPG. 
 
H. Kanzaki, M. Chiba, Y. Shimizu, and H. Mitani (2001)
64
 examined the 
consequences of cell-to cell interactions between peripheral blood mononuclear 
cells (PBMCs) and PDL cells during osteoclastogenesis indirectly with PDL cells 
for two to four weeks. PBMCs that were directly co-cultured with PDL cells 
formed significantly more resorption pits on dentin slices than did PBMCs that 
were cultured alone. PDL cells expressed both RANKL and OPG mRNA. They 
concluded that PDL cells support osteoclastogenesis through cell to- cell contact. 
PDL cells might regulate osteoclastogenesis by opposing mechanisms: stimulation 
of resorptive activity by RANKL and inhibition by OPG thus affecting processes 
such as periodontitis and orthodontic tooth movement. 
 
Shimizu-Ishiura M, Kawana F, Sasaki T (2002)
65
 examined the effects of OPG 
administration on the distribution, ultrastructure and vacuolar-type H+-ATPase 
expression of osteoclasts and resulting trabecular bone loss in the femurs of 
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ovariectomized (OVX) mice. Two-month-old female mice were allocated to the 
following groups: (1) pretreatment base-line controls; (2) untreated sham-operated 
controls; (3) untreated OVX; and (4) OPG-administered OVX mice. 
Postoperatively, OPG (0.3 mg kg(-1) day(-1)) was intraperitoneally administered 
daily to OVX mice for 7 days. On postoperative day 7, all mice were sacrificed, 
and the dissected femurs were examined by means of light and immunoelectron 
microscopy and quantitative backscattered-electron image analysis. 
Backscattered-electron examination revealed that trabecular bone area/unit 
medullary area in untreated OVX mice was significantly lower than that of base-
line control and sham-operated control mice. Compared with untreated OVX 
mice, OPG administration to OVX mice significantly increased trabecular bone 
area, which was similar to that of sham-operated control mice. Surprisingly, the 
number of TRAP-positive osteoclasts along the trabecular bone surfaces in OPG-
administered OVX mice was not significantly decreased compared with that of 
sham-operated control and untreated OVX mice. Ultrastructurally, OPG 
administration caused disappearance of ruffled borders in most osteoclasts, but 
induced neither necrotic nor apoptotic changes. In addition, the expression of 
vacuolar-type H+-ATPase in osteoclasts was decreased by OPG administration. 
Their results suggest that low-dose OPG administration significantly reduces 
trabecular bone loss in OVX mice via impairment of the structure and bone 
resorbing activity of osteoclasts. 
 
Sasaki T (2003)
66
 in an examination of preosteoclast (pOC) culture demonstrated 
that RANKL and OPG are important regulators of not only the terminal 
differentiation of OC but also their resorptive function. The study showed pOCs 
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formed without any additives expressed tartrate-resistant acid phosphatase 
(TRAP), but showed little resorptive activity. pOC treated with RANKL became 
TRAP-positive OC, which expressed intense vacuolar-type H(+)-ATPase and 
exhibited prominent resorptive activity. Such effects of RANKL on pOC were 
completely inhibited by addition of OPG. OPG inhibited ruffled border formation 
in mature OC and reduced their resorptive activity, and  also induced apoptosis of 
some OC. Although OPG administration significantly reduced  trabecular bone 
loss in the femurs of ovariectomized (OVX) mice, the number of TRAP- positive 
OC in OPG-administered OVX mice was not significantly decreased. Rather, 
OPG  administration caused the disappearance of ruffled borders and decreased 
H(+)-ATPase expression in most OC. OPG deficiency causes severe osteoporosis. 
RANKL localization and OC induction in periodontal ligament (PDL) during 
experimental movement of incisors in OPG-deficient mice was also examined. 
Compared to wild-type OPG (+/+) littermates, after force application, TRAP-
positive OC were markedly increased in the PDL and alveolar bone was severely 
destroyed in OPG-deficient mice. In both wild-type and OPG-deficient mice, 
RANKL expression in osteoblasts and fibroblasts became stronger by force 
application. These in vitro and in vivo studies suggest that RANKL and OPG are 
important regulators of not only the terminal differentiation of OC but also their 
resorptive function. Lastly, he examined the expression of H(+)-ATPase, 
cathepsin K, and matrix metalloproteinase-9 in odontoclasts (OdC) during 
physiological root resorption in human deciduous teeth, and found that there were 
no differences in the expression of these molecules between OC and OdC. 
RANKL was also detected in stromal cells located on resorbing dentine surfaces. 
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This suggests that there is a common mechanism in cellular resorption of 
mineralized tissues such as bone and teeth. 
 
Yamazaki H, Sasaki T (2005)
67
 using OPG-deficient mice, attempted to clarify 
the differentiation and ultrastructure of osteoclasts located on the destroyed 
growth plate cartilage and trabecular bone matrix in long bones. In (-/-) 
homozygous OPG knockout mice, adjacent to the growth plate cartilage, the 
formation of bone trabeculae without a calcified cartilaginous core resulted in an 
irregular chondrocyte distribution in the growth plate cartilage. At the 
metaphyseal ossification center, TRAP-positive osteoclasts showed unusual 
localization on both type-II collagen-positive cartilage and type-I collagen-
positive bone matrix. Osteoclasts located on cartilage matrix lacked a typical 
ruffled border structure, but formed resorption lacunae. During growth plate 
cartilage destruction, osteoclasts formed ruffled border structures on bone matrix 
deposited on the remaining cartilage surfaces. These findings suggest that, in OPG 
(-/-) mice, osteoclast structure differs, depending on the matrix of either cartilage 
or bone. Then, they examined the effects of OPG administration on the internal 
trabecular bone structure and osteoclast differentiation in OPG (-/-) mice. OPG 
administration to OPG (-/-) mice significantly inhibited trabecular bone loss and 
maintained the internal trabecular bone structure, but did not reduce the osteoclast 
number on bone trabeculae. For most osteoclasts, OPG administration caused 
disappearance or reduction of the ruffled border, but induced neither necrotic nor 
apoptotic damages. These results suggest that OPG administration is an effective 
means of maintaining the internal structure and volume of trabecular bone in 
metabolic bone diseases by inhibition of osteoclastic bone resorption. 
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Baud'huin M, Duplomb L, Ruiz Velasco C, Fortun Y, Heymann D, Padrines M 
(2007)
68
 showed that any dysregulation of their respective expression of 
RANKL/OPG leads to pathological conditions. Furthermore, they also 
demonstrated that the OPG-RANK-RANKL system modulates cancer cell 
migration, thus controlling the development of bone metastases. 
 
Ominsky MS, Kostenuik PJ, Cranmer P, Smith SY, Atkinson JE (2007)
69
 
investigated the safety and pharmacology of the RANKL inhibitor OPG-Fc in 
gonad-intact cynomolgus monkeys. Cortical and trabecular volumetric BMD and 
BMC, cortical thickness, and cross-sectional moment of inertia were significantly 
increased by OPG-Fc treatment at the proximal tibia and distal radius metaphyses. 
Increases in cortical thickness were associated with significantly greater periosteal 
circumference. They inferred that OPG-Fc increased cortical and trabecular BMD 
and BMC in young gonad-intact cynomolgus monkeys. 
 
Brendan F. Boyce, and Lianping Xing (2008)
70
 demonstrated that hypertrophic 
and to a lesser extent prehypertrophic chondrocytes express RANKL, OPG and 
RANK. Mice deficient in RANKL, RANK and NF-κB p50 and p52 develop 
osteopetrosis because they do not form osteoclasts and have thickened 
hypertrophic cartilage zones in their growth plates. This defect is rectified 
spontaneously between 2 and 3 weeks of age in the RANKL−/− and RANK−/− 
mice and 2–3 weeks later in the NF-κB p50 and p52 double knockout mice. The  
precise role of RANKL/RANK/NF-κB signaling in chondrocytes during 
endochondral ossification remains poorly understood, but these findings suggest 
that it may regulate the lifespan of hypertrophic chondrocytes through NF-κB p50 
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and p52-regulated genes at least temporarily, similar to MMP-9 (11), which is 
regulated by NF-κB. All of these knockout mice are dwarfed, suggesting that 
RANKL/RANK/NF-κB signaling during the first 2–3 weeks of life is essential for 
attainment of full skeletal growth. 
 
Ominsky MS, Li X, Asuncion FJ, Barrero M, Warmington KS, Dwyer D, 
Stolina M, Geng Z, Grisanti M, Tan HL, Corbin T, McCabe J, Simonet WS, Ke 
HZ, Kostenuik PJ. (2008)
71
 examined whether the RANKL inhibitor 
osteoprotegerin (OPG) would preserve bone volume, density, and strength in 
ovariectomized (OVX) rats. OVX was associated with significantly greater serum 
RANKL. They found that OPG markedly reduced osteoclast surface and serum 
TRACP5b while completely preventing OVX-associated bone loss in the lumbar 
vertebrae, distal femur, and femur neck. Vertebrae from OPG-treated rats had 
increased dry and ash weight, with no significant differences in tissue 
mineralization versus OVX controls. Bone strength was also significantly 
increased by OPG. 
 
Stolina M, Schett G, Dwyer D, Vonderfecht S, Middleton S, Duryea D, Pacheco 
E, Van G, Bolon B, Feige U, Zack D, Kostenuik P (2009)
72
 demonstrated that 
RANKL inhibition prevented local and systemic bone loss without significantly 
inhibiting local or systemic inflammatory parameters. Lewis rats with established 
rat adjuvant-induced arthritis (AIA) or collagen-induced arthritis (CIA) were 
treated for 10 days (from day 4 post onset) with RANKL inhibitor 
(osteoprotegerin (OPG)-Fc). Local inflammation was evaluated by monitoring 
hind paw swelling. Bone mineral density (BMD) of paws and lumbar vertebrae 
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was assessed by dual X-ray absorptiometry. OPG-Fc reduced BMD loss in ankles 
and vertebrae in both models, but had no effect on paw swelling. They found that 
RANKL inhibition by OPG-Fc did not lessen systemic cytokine levels in either 
model but prevented local and systemic bone loss. 
 
Bastos MF, Brilhante FV, Gonçalves TE, Pires AG, Napimoga MH, Marques 
MR, Duarte PM.(2010)
73
 evaluated the ligature-induced bone loss (BL) and 
quality of tooth-supporting lveolar bone in spontaneously hypertensive rats 
(SHRs) by histometric, histochemical, and immunohistochemical analyses. They 
found a decreased expression of RANKL in the treated SHR group. They 
concluded that SHRs present harmful alterations in the quality of tooth-supporting 
bone and attributed this to the decreased the expression of bone-resorption 
markers. 
 
Kanzaki H, Chiba M, Shimizu Y, Mitani H. (2002)
75
 examined how mechanical 
stress affects the osteoclastogenesis-supporting activity of PDL cells. PDL cells 
were compressed continuously and then cocultured with peripheral blood 
mononuclear cells (PBMCs) for 4 weeks. PDL cells under mechanical stress up-
regulated osteoclastogenesis from PBMCs. Furthermore, the expression of 
RANKL mRNA and protein in PDL cells increased with compressive force in 
parallel with the change in the number of osteoclasts. In addition, cyclo- 
oxygenase 2 (COX-2) mRNA expression was induced by compressive force, and  
indomethacin inhibited the RANKL up-regulation resulting from compressive 
force. PDL cells under compressive force exhibited significantly increased 
prostaglandin E2 (PGE2) production in comparison with control PDL cells. 
 
Review of Literature   
 
 
 29 
Exogenous PGE2 treatment increased RANKL mRNA expression in PDL cells. 
OPG expression remained constant throughout compressive force or PGE2 
treatment. They concluded that compressive force up-regulated RANKL 
expression in PDL cells. Furthermore, RANKL up-regulation in mechanically 
stressed PDL cells was dependent on PGE2. 
 
Tsuji K, Uno K, Zhang GX, Tamura M (2004)
76
 studied the mRNA expression of 
osteoprotegerin (OPG), receptor activator of NF-kappa B ligand (RANKL), tissue 
inhibitor of matrix metalloprotease (TIMP)-1 and -2, and matrix metalloprotease 
(MMP)-1 and -2 by human periodontal ligament. (PDL) cells under intermittent 
tensile stress using a Flexercell Strain Unit. Analysis by reverse transcriptase-
polymerase chain reaction showed that mechanical force up regulated OPG 
mRNA. They also demonstrated that the protein concentration of OPG in 
conditioned medium increased upon loading with tensile stress, as determined by 
enzyme-linked immunosorbent assay. TIMP-1 and -2 mRNA levels also 
increased, whereas levels of RANKL, MMP-1, and MMP-2 mRNA were barely 
affected. We further examined the effect of loading with tensile stress and 
addition of Salmonella abortus equi lipopolysaccharide (LPS) on the mRNA 
expression of PDL cells. The amount of OPG mRNA induced by mechanical 
strain was found to decrease with the addition of LPS to cultures. The induction of 
OPG mRNA expression by stretching was inhibited in the presence of 
indomethacin or genistein, whereas TIMP-1 mRNA expression induced by 
stretching was inhibited by the addition of cycloheximide, suggesting that tensile 
stress regulates cyclooxygenase activities, tyrosine phosphorylation, and de novo 
protein synthesis in PDL cells through the induction of OPG and TIMP-1 mRNA 
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expression. These results provide evidence that the mechanical stimulus of 
stretching is responsible for the observed regulation of bone resorption and tissue 
degradation in PDL tissue. 
 
Ogasawara T, Yoshimine Y, Kiyoshima T, Kobayashi I, Matsuo K, Akamine A, 
Sakai H. (2004)
77
 suggested that an autocrine mechanism of RANKL-RANK 
exists in osteoclast, which is heightened in the pathological conditions. They 
examined the in situ expression of receptor activator of nuclear factor-kappaB 
ligand (RANKL), receptor activator of nuclear factor-kappaB (RANK), 
osteoprotegerin, interleukin-1beta (IL-1beta) and tumor necrosis factor alpha 
(TNFalpha) in the osteoclasts of rat periodontal tissue. Four-week-old Wistar rats 
were used. Tooth movement was performed by the Waldo method, and the 
pathological bone resorption was induced. The demineralized maxillae and 
mandiblae were embedded with paraffin. In situ hybridization was performed to 
detect RANKL, RANK, osteoprotegerin, IL-1beta, and TNFalpha mRNAs in 
osteoclasts and other cells using the specific RNA probes, respectively. Both 
RANKL and RANK were concomitantly expressed in some osteoclasts. RANKL 
was also positive in osteoblasts and PDLs. No IL-1beta- and TNFalpha-positive 
osteoclast was noted. The positive signals of osteoprotegerin were detected in 
almost all osteoblasts, PDLs and odontoblasts. No osteoprotegerin-positive 
osteoclasts were observed. The number and the distribution pattern of RANKL- 
and RANK-expressing osteoclasts changed when orthodontic excessive force was 
applied to periodontal tissue. In addition, IL-1beta and TNFalpha were shown to 
be expressed in osteoclasts under pathological status. They inferred that an 
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autocrine mechanism of RANKL-RANK exists in osteoclast, which is heightened 
in the pathological conditions. Furthermore, the autocrine mechanism of IL-1beta 
and TNFalpha is also provided in osteoclast under pathological condition. These 
autocrine mechanisms therefore seem to regulate the osteoclast function in both 
physiological and pathological conditions. 
 
Yamamoto T, Kita M, Kimura I, Oseko F, Terauchi R, Takahashi K, Kubo T, 
Kanamura N (2006)
78
 investigated the effect of mechanical stress as hydrostatic 
pressure (HP) on cytokine expression in human PDL cells. The hPDL cells were 
obtained from a healthy maxillary third molar. After the third to fourth passage, 
the cells were exposed to HP ranging from 1 to 6 MPa. Total RNA was extracted 
and the expression of cytokine mRNA was determined by RT-PCR. The exposure 
to 6 MPa of HP caused no morphological changes of hPDL cells, and did not 
affect the cellular viability. No expression of IL-1beta, IL-6, IL-8, TNF-alpha, 
receptor activator of NF-lambdaB (RANK), receptor activator of NF-lambdaB 
ligand (RANKL), or osteoprotegerin mRNA was observed in the control cells 
under atmospheric pressure, whereas, in hPDL cells treated with HP, a pressure-
dependent enhancement of IL-6, IL-8, RANKL, and OPG mRNA expression was 
observed between 10 and 60 min after the exposure to HP. These results suggest 
that hPDL cells may play a role in the production of cytokines in response to 
mechanical stress in vivo. 
 
H. Kanzaki, M. Chiba, A. Sato, A. Miyagawa, K. Arai, S. Nukatsuka, and H. 
Mitani (2006)
78
 subjected a conditioned media of PDL cells to cyclical tensile 
force. They demonstrated that cyclical tensile force up-regulated not only RANKL 
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mRNA expression, but also OPG mRNA expression in PDL cells. Tensile force 
up-regulated TGF-beta expression in PDL cells as well. Administration of 
neutralizing antibodies to TGF-beta inhibited OPG upregulation under cyclical 
tensile-force stimulation in a dose-dependent manner. Additionally, the 
osteoclastogenesis-inhibitory effect of the conditioned media of PDL cells under 
cyclical tensile force was partially rescued by the administration of TGF-beta 
neutralizing antibodies. They concluded that tensile force inhibited the 
osteoclastogenesis-supporting activity of PDL cells by inducing the up-regulation 
of OPG via TGF-beta stimulation. 
 
Tatsumi S, Ishii K, Amizuka N, Li M, Kobayashi T, Kohno K, Ito M, Takeshita 
S, Ikeda K (2007)
79
 suggested that at least in response to mechanical forces, 
osteocytes regulate the recruitment of osteoclasts to sites of bone resorption by 
inducing the expression of RANKL by osteoblastic cells in the local micro-
environment. 
 
Nakajima R, Yamaguchi M, Kojima T, Takano M, Kasai K (2008)
80
applied a 
compression force of 0.5-4.0 g/cm2 to human periodontal ligament cells for 0-24 
h and the amounts of soluble RANKL (sRANKL) and fibroblast growth factor-2 
were measured using an enzyme-linked immunosorbent assay. They found that 
the applied compression force induced higher levels of sRANKL and fibroblast 
growth factor-2 in both a time- and magnitude-dependent manner. 
 
Kook SH, Son YO, Choe Y, Kim JH, Jeon YM, Heo JS, Kim JG, Lee JC 
(2009)
81
 examined how mechanical force affects the nature of human gingival 
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fibroblasts to produce osteoprotegerin and inhibit osteoclastogenesis. Human 
gingival fibroblasts were exposed to mechanical force by centrifugation for 90 
min at a magnitude of approximately 50 g/cm(2). The levels of osteoprotegerin, 
receptor activator of nuclear factor-kappaB ligand (RANKL), interleukin-1beta 
and tumor necrosis factor-alpha were measured at various time-points after 
applying the force. Centrifugal force stimulated the expression of osteoprotegerin, 
RANKL, interleukin-1beta and tumor necrosis factor-alpha by the cells, and 
produced a relatively high osteoprotegerin to RANKL ratio at the protein level. 
Both interleukin-1beta and tumor necrosis factor-alpha accelerated the force-
induced production of osteoprotegerin, which was inhibited significantly by the 
addition of anti-(interleukin-1beta) immunoglobulin Ig isotype; IgG (rabbit 
polyclonal). However, the addition of anti-(tumor necrosis factor-alpha) 
immunoglobulin Ig isotype; IgG1 (mouse monoclonal) had no effect. Centrifugal 
force also had an inhibitory effect on osteoclast formation. They concluded that 
application of centrifugal force to human gingival fibroblasts accelerates 
osteoprotegerin production by these cells, which stimulates the potential of human 
gingival fibroblasts to suppress osteoclastogenesis.  
 
Sanuki Rina, Shionome Chieko, Kuwabara Akiko, Mitsui Narihiro, Koyama 
Yuki, Suzuki Naoto, Zhang Fan Shimizu, Noriyoshi, Maeno, Masao (2010)
82
 
examined the effect of compressive force on the production of PGE2, 
cyclooxygenase-2 (COX-2), macrophage colony-stimulating factor (M-CSF), 
receptor activator of NF-êB ligand (RANKL), and osteoprotegerin (OPG) using 
osteoblastic MC3T3-E1 cells. They found that as the compressive force increased, 
PGE2 production and the expression of COX-2, M-CSF, and RANKL increased, 
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whereas OPG expression decreased. Celecoxib, a specific inhibitor of COX-2, 
blocked the stimulatory effect of CF on TRAP staining and the production of 
PGE2, M-CSF, RANKL, and OPG. 
 
Zhang F, Wang CL, Koyama Y, Mitsui N, Shionome C, Sanuki R, Suzuki N, 
Mayahara K, Shimizu N, Maeno M. (2010)
83
 evaluated the effects of 
compressive force during orthodontic tooth movement on cytokines released from 
periodontal ligament fibroblasts. Their results indicate that compressive force 
induces the expression of IL-17s and their receptors in osteoblast-like cells and 
that IL-17s and their receptors produced in response to compressive force may 
affect osteoclastogenesis through the expression of RANKL, M-CSF, and OPG. 
 
The involvement of RANKL and OPG in bone remodeling during 
orthodontic tooth movement  
Eva Low, Hans Zoellner, Om Prakash Kharbanda, and M. Ali Darendeliler 
(2005)
84
 showed by densitometric analysis that an increase in background levels 
of OPG mRNA was evident in bony tissues subjected to orthodontic forces. 
RANKL and OPG levels were seen to increase in the environment during root 
resorption with the application of heavy forces. They might play a significant role 
during root resorption processes after orthodontic tooth movement. 
 
Y Nishijima, M Yamaguchi, T Kojima, N Aihara, R Nakajima, K Kasai (2006)
85
 
conducted a study to determine the levels of the receptor activator of NFkB ligand 
(RANKL) and osteoprotegerin (OPG) in the gingival crevicular fluid (GCF) 
during orthodontic tooth movement and to investigate the effect of compression 
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force on RANKL and OPG production from human periodontal ligament (hPDL) 
cells. Enzyme-linked immunosorbent assay (ELISA) kits were used to determine 
RANKL and OPG levels in the GCF collected at the distal cervical margins of the 
experimental and control teeth 0, 1, 24, and 168 h after the retracting force was 
applied. GCF levels of RANKL were significantly higher, and the levels of OPG 
significantly lower, in the experimental canines than in the control teeth at 24 h, 
but there were no such significant differences at 0, 1, or 168 h. In vitro study 
indicated that the compression force significantly increased the secretion of 
RANKL and decreased that of OPG in hPDL cells in a time and force magnitude-
dependent manner. The compression stimulated secretion of RANKL increased 
approximately 16.7-fold and that of OPG decreased 2.9-fold, as compared with 
the control. 
 
Kawasaki K, Takahashi T, Yamaguchi M, Kasai K (2006)
86
 compared the levels 
of the receptor activator of NFkB ligand (RANKL) and osteoprotegerin (OPG) in 
the gingival crevicular fluid (GCF) during orthodontic tooth movement in juvenile 
and adult patients. GCF was collected from the distal cervical margins of the 
experimental and control teeth at 0, 1, 24, and 168 h after application of a 
retracting force. Enzyme-linked immunosorbent assay kits were used to determine 
RANKL and OPG levels in the GCF samples. The amount of tooth movement for 
juveniles was larger than for adults after 168 h. Further, after 24 h RANKL levels 
were increased and those of OPG decreased in GCF samples from the 
compression side during orthodontic tooth movement in both juveniles and adults. 
The RANKL/OPG ratio in GCF from adult patients was lower than that in the 
juvenile patient samples. Their results suggest that the age-related decrease in 
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amount of tooth movement may be related to a decrease in RANKL/OPG ratio in 
GCF during the early stages of orthodontic tooth movement. 
 
Nakao K, Goto T, Gunjigake KK, Konoo T, Kobayashi S, Yamaguchi K (2007)
87
  
effectively demonstrated that intermittent force induces high RANKL expression 
in human periodontal ligament cells. They examined the  molecular mechanism in 
human periodontal ligament (PDL) cells stimulated by an intermittent force. PDL 
cells were subjected to compressive force (2.0 or 5.0 g/cm(2)) for 2-4 days. 
Continuous or intermittent force was applied all day or for 8 hrs per day, 
respectively. At days 3 and 4, cell damage was less with intermittent force than 
with continuous force. At day 4, RANKL and IL-1beta expressions were greater 
with intermittent force than with continuous force. An IL-1 receptor antagonist 
inhibited the compressive force-induced RANKL expression. These findings 
indicate that IL-1beta is an autocrine factor regulating compressive force-induced 
RANKL expression in PDL cells, and that intermittent force can effectively 
induce RANKL in PDL cells with less cell damage. 
 
Matthew D. Dunn, Chan Ho Park, Paul J. Kostenuik, Sunil Kapila, and 
William V. Giannobile (2007)
88
 examined the role of OPG in regulating 
mechanically induced bone modeling in a rat model of orthodontic tooth 
movement. The maxillary first molars of male Sprague-Dawley rats were moved 
mesially using a calibrated nickel–titanium spring attached to the maxillary incisor 
teeth. Two different doses (0.5 mg/kg, 5.0 mg/kg) of a recombinant fusion protein 
(OPG-Fc), were injected twice weekly mesial to the first molars. Tooth movement 
was measured using stone casts that were scanned and magnified. Changes in 
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bone quantity were measured using micro-computed tomography and 
histomorphometric analysis was used to quantify osteoclasts and volumetric 
parameters. The 5.0 mg/kg OPG-Fc dose showed a potent reduction in mesial 
molar movement and osteoclast numbers compared to controls (p<0.01). The 
molar movement was inhibited by 45.7%, 70.6%, and 78.7% compared to controls 
at days 7, 14, and 21 respectively, with the high dose of OPG. The 0.5 mg dose 
also significantly (p<0.05) inhibited molar movement at days 7 (43.8%) and 14 
(31.8%). The 5.0 mg/kg OPG-Fc dose showed a potent reduction in mesial molar 
movement and osteoclast numbers compared to controls (p<0.01). The molar 
movement was inhibited by 45.7%, 70.6%, and 78.7% compared to controls at 
days 7, 14, and 21 respectively, with the high dose of OPG. The 0.5 mg dose also 
significantly (p<0.05) inhibited molar movement at days 7 (43.8%) and 14 
(31.8%). They concluded that local delivery of OPG-Fc inhibits 
osteoclastogenesis and tooth movement at targeted dental sites. 
 
Hilal Uslu Toygar; Beyza Hancioglu Kircelli; Sule Bulut; Nurzen Sezgin; 
Bahar Tasdelen (2008)
89
 investigated the level of osteoprotegerin (OPG) in 
gingival crevicular fluid (GCF) during tooth movement. Twelve patients (13–17 
years of age) requiring canine distalization participated in the study. GCF 
sampling was done at baseline, 1 hour, 24 hours, 168 hours, 1 month, and 3 
months from the distal sites of the test and with control teeth after the application 
of mechanical stress. OPG concentration was detected by enzyme-linked 
immunosorbent assay. OPG concentrations in distal sites of the test teeth were 
decreased in a time-dependent manner. The decrease is significant when 
compared with the baseline measurements (P < 0.038).Variability was detected in 
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the levels of OPG concentration in the distal sites of the control tooth throughout 
the experimental period. They concluded that OPG is one of the key mediators 
responsible for alveolar bone remodeling during tooth movement. 
 
Fujita S, Yamaguchi M, Utsunomiya T, Yamamoto H, Kasai K. 
(2008)
90
examined the effects of low-energy laser irradiation on expressions of 
RANK, RANKL, and OPG during experimental tooth movement. To induce 
experimental tooth movement in rats, 10 g of orthodontic force was applied to the 
molars. Next, a Ga-Al-As diode laser was used to irradiate the area around the 
moved tooth and the amount of tooth movement was measured for 7 days. 
Immunohistochemical staining with RANK, RANKL, and OPG was performed. 
Real time PCR was also performed to elucidate the expression of RANK in 
irradiated rat osteoclast precursor cells in vitro. They found that in the irradiation 
group, the amount of tooth movement was significantly greater than in the non-
irradiation group by the end of the experimental period. Cells that showed positive 
immunoreactions to the primary antibodies of RANKL and RANK were 
significantly increased in the irradiation group on day 2 and 3, compared with the 
non-irradiation group. In contrast, the expression of OPG was not changed. 
Further, RANK expression in osteoclast precursor cells was detected at an early 
stage (day 2 and 3) in the irradiation group.  
 
Garlet TP, Coelho U, Repeke CE, Silva JS, Cunha Fde Q, Garlet GP (2008)
91
 
investigated the pattern of mRNAs expression encoding for osteoblast and 
osteoclast related chemokines, and further correlated them with the profile of bone 
remodeling markers in palatal and buccal sides of tooth under orthodontic force, 
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where tensile (T) and compressive (C) forces, respectively, predominate. Real-
time PCR was performed with periodontal ligament mRNA from samples of T 
and C sides of human teeth submitted to rapid maxillary expansion, while 
periodontal ligament of normal teeth were used as controls. Results showed that 
both T and C sides exhibited significant higher expression of all targets when 
compared to controls. Comparing C and T sides, C side exhibited higher 
expression of MCP-1/CCL2, MIP-1alpha/CCL3 and RANKL, while T side 
presented higher expression of OCN. The expression of RANTES/CCL5 and 
SDF-1/CXCL12 was similar in C and T sides. Their data demonstrate a 
differential expression of chemokines in compressed and stretched PDL during 
orthodontic tooth movement, suggesting that chemokines pattern may contribute 
to the differential bone remodeling in response to orthodontic force through the 
establishment of distinct microenvironments in compression and tension sides. 
 
Yamaguchi (2009)
92
 found that concentrations of RANKL in GCF increased 
during orthodontic tooth movement, and the ratio of concentration of RANKL to 
that of OPG in the GCF was significantly higher than in control sites. The study 
has shown the presence of RANKL and RANK in periodontal tissues during 
experimental tooth movement of rat molars, and that PDL cells under mechanical 
stress may induce osteoclastogenesis through upregulation of RANKL expression 
during orthodontic tooth movement. 
 
Lijun Tan; Yijin Ren; Jun Wang; Lingyong Jiang; Hui Cheng; Andrew 
Sandham; Zhihe Zhao (2009)
93
 tested the null hypothesis that increased tooth 
displacement in ovariectomized rats is not related to differential expressions of 
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OPG and RANKL in the periodontium. Eighty-four 12-week female rats were 
used; half were ovariectomized and half were not. Three months later, the 
maxillary first molar was moved mesially. Groups of rats were sacrificed at days 
0, 1, 3, 5, 7, 10, and 14 after activation. Tooth movement was measured at each 
time point. OPG and RANKL expressions were examined through 
immunohistochemistry. Ovariectomized and nonovariectomized rats showed 
three-phase tooth movement. In both groups, OPG expression increased at the 
tension area and RANKL increased at the pressure area. The OPG/RANKL ratio 
coincided with tooth movement, especially in the linear phase from 7 to 14 days. 
They concluded that the increased rate of tooth movement in ovariectomized rats 
was related to differential expressions of OPG and RANKL. 
 
Patricia Joyce Brooks; Dorrin Nilforoushan; Morris Frank Manolson; Craig A. 
Simmons; Siew-Ging Gong (2009)
94
 employed a rat model of early orthodontic 
tooth movement using a split-mouth design (where contralateral side serves as a 
control) and performed immunohistochemical  staining to map the spatial 
expression patterns of RANKL at 3 and 24 hours after appliance insertion. They 
observed increased expression of RANKL, a molecule associated with osteoclastic 
differentiation, in the compression sites of the periodontal ligament subjected to 3 
hours of force. The early RANKL expression indicates that at this early stage cells 
are involved in osteoclast precursor signaling. 
 
Joanna Tyrovola, Despoina Perea, Dimitrios Halazonetis, Ismene Dontas, 
Ionnis Vlachos, Margarita Makou (2010)
95
carried out a study to determine the 
levels of OPG and soluble RANKL in blood serum and GCF relative to the degree 
 
Review of Literature   
 
 
 41 
of orthodontic root resorption in a rat model. They demonstrated a positive linear 
correlation between the initial concentration of RANKL in the blood serum and 
the degree of root resorption. The ratio of the initial concentrations of OPG to 
RANKL in the blood serum proved to be an independent prognostic factor of the 
degree of root resorption. The concentration of OPG in blood serum decreased 
significantly in cases of severe root resorption. 
 
INTERLEUKIN – 10 AND ORTHODONTIC TOOTH MOVEMENT 
 
Alhashimi n et al (2000)
96
 in their study was to analyze effects of mechanical 
force during orthodontic tooth movement, in the pressure zone, on the induction of 
interferon-gamma (IFN-gamma) as a proinflammatory cytokine of Th1 type and 
interleukin-4 (IL-4)/IL-10 as anti-inflammatory cytokines of Th2 type. In 12 
Wistar rats 40-45 days old, the maxillary first molar was moved mesially by 
means of a closed coil spring for 3, 7, and 10 days. The contralateral side served 
as a control. IFN-gamma, IL-4, and IL-10 mRNA were determined by in situ, 
hybridization, and protein levels of IFN-gamma was measured by 
immunohistochemistry. Induction of IFN-gamma at both mRNA and protein 
levels was significantly higher on the experimental side than on the contralateral 
control side on day 3. The signal gradually became stronger on day 7 and 
remained high on day 10. Cytokines of the Th2 type (IL-4 and IL-10) were not 
detected at all examined time points in both pressure and contralateral control 
sides. Considering the potential immunoregulatory roles played by IFN-gamma, 
our data suggest that IFN-gamma may be involved in periodontium remodeling  
during orthodontic tooth movement. 
 
Review of Literature   
 
 
 42 
Andrade I jr et al (2009)
97
 in their study aimed to investigate whether the CCR5-
receptor influences these events and, consequently, orthodontic tooth movement. 
An orthodontic appliance was placed in wild-type mice (WT) and CCR5-deficient 
mice (CCR5(-/-)). The expression of mediators involved in bone remodeling was 
evaluated in periodontal tissues by Real-time PCR. The number of TRAP-positive 
osteoclasts and the expression of cathepsin K, RANKL, and MMP13 were 
significantly higher in CCR5(-/-). Meanwhile, the expression of two osteoblastic 
differentiation markers, RUNX2 and osteocalcin, and that of bone resorption 
regulators, IL-10 and OPG, were lower in CCR5(-/-). Analysis of the data also 
showed that CCR5(-/-) exhibited a greater amount of tooth movement after 7 days 
of mechanical loading. The results suggested that CCR5 might be a down-
regulator of alveolar bone resorption during orthodontic movement. 
 
Melissa grant et al (2012)
98
 in their study investigated changes in cytokines and 
biomarkers of  bone and tissue metabolism within gingival crevicular fluid (GCF) 
from patients undergoing  orthodontic treatment. GCF was collected on 
Periopaper™ strips (Oraflow Inc., USA) from 20 volunteers at baseline, before 
tooth extraction and appliance placement and then at  intervals during orthodontic 
treatment. Samples were taken 10 weeks following first appliance  placement: at 
four hours; 7 days; and 42 days after application of distalising forces to maxillary 
canine teeth. Cytokines (GM-CSF, interferon-gamma, IL-1beta, IL-2, IL-4, IL-5, 
IL-6, IL-8, IL-10 and TNFalpha), tissue biomarkers (MMP-9, TIMP-1 & 2) and 
bone metabolism indicators (RANKL and OPG) were measured in GCF using 
multiplex assays. Tension sites adjacent to canines showed significant increases in 
IL-1beta, IL-8, TNFalpha, MMP-9 and TIMPs 1 and 2 across all time points 
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following force application, while compression sites exhibited increases in IL-
1beta and IL-8 after 4 hours, MMP-9 after 7 and 42 days and RANKL after 42 
days. These data demonstrate that high levels of pro-inflammatory cytokines and 
biomarkers of tissue and bone metabolism in GCF are associated with orthodontic 
force application. Elevated levels were evident at 4 hours but continued for 
periods of up to 6 weeks. The data suggest that GCF biomarker analysis may help 
optimise orthodontic forces for individual patients. 
 
INTERLEUKIN – 10 GENERAL FUNCTIONS 
 
Mei hua hong et al (2000)
99
 stated that Interleukin-10 (IL-10) inhibits osteoclast 
(OC) formation in rat and mouse systems. However, little is known concerning the 
mechanism of this inhibitory effect. Using a coculture system of mouse bone 
marrow cells and primary osteoblastic cells (POB), we evaluated the potential 
target cells for IL-10 and components of the IL-10 activating pathway. In the 
coculture system, IL-10 treatment abolished OC differentiation in a dose-
dependent manner. This inhibitory effect occurred regardless of the stage of 
cellular proliferation and differentiation, suggesting that IL-10 may act on a 
variety of genes participating in OC formation. IL-10 specifically abrogated the 
production of IL-6 by enriched bone marrow-derived mononuclear cells (BMM) 
but not by osteoblastic cells. IL-10 treatment also stimulated the binding of a 
protein in the BMM to an IL-10 response element, whereas no such activation was 
induced in  osteoblastic cells. In contrast, interferon g (IFN-g), another inhibitory 
factor, stimulated tyrosine-phosphorylated proteins to bind to an IL-10 response 
element in both monocytes and osteoblastic cells. These data suggest that the 
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BMM are the direct target of IL-10 action. Importantly, oligonucleotide-specific 
precipitation confirmed that IL-10 treatment strongly augmented 88, 85, and 70 
kDa tyrosine-phosphorylated proteins in BMM. Taken together, these data show 
that IL-10 inhibits mouse OC formation by acting directly on hemopoietic OC 
precursor, through a novel signal transduction and activation pathway. 
 
Giorgio Trinchieri (2007)
100
 in his study stated that Interleukin (IL)-10 is a 
cytokine that Modulates  both innate and adaptive immunity, primarily by exerting  
antiinfl ammatory effects. IL-10 was originally thought to be produced only by T 
helper (Th)2 cells, but is now known to be made by a variety of cell types. During 
many infections, CD4+ T cells produce both interferon (IFN)-γ, the signature Th1 
cytokine, and IL-10. New data now show that the IL-10 produced by effector Th1 
cells helps limit the collateral damage caused by exaggerated infl ammation. But 
this control may also limit the effectiveness of the immune response, resulting in a 
failure to fully eliminate pathogens. 
 
David L. Cochran (2008)
101
 stated that Inflammation and bone loss are hallmarks 
of periodontal disease (PD). The question is how the former leads to the latter. 
Accumulated evidence demonstrates that PD involves bacterially derived factors 
and antigens that stimulate a local inflammatory reaction and activation of the 
innate immune system. Proinflammatory molecules and cytokine networks play 
essential roles in this process. Interleukin-1 and tumor necrosis factor-alpha seem 
to be primary molecules that, in turn, influence cells in the lesion. Antigen-
stimulated lymphocytes (B and T cells) also seem to be important. Eventually, a 
cascade of events leads to osteoclastogenesis and subsequent bone loss via the 
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receptor activator of nuclear factor-kappa B (RANK)–RANK ligand (RANKL)–
osteoprotegerin (OPG) axis. This axis and its regulation are not unique to PD but 
rather are critical for pathologic lesions involving chronic inflammation. Multiple 
lines of evidence in models of PD clearly indicate that increases in RANKL 
mRNA expression and protein production  increase the RANKL/OPG ratio and 
stimulate the differentiation of macrophage precursor cells into osteoclasts. They 
also stimulate the maturation and survival of the osteoclast, leading to bone loss. 
OPG mRNA expression and protein production do not generally seem to be 
increased in the periodontitis lesion. Studies of RANKL and OPG transgenic and 
knockout animals provide further support for the involvement of these molecules 
in the tissue loss observed in PD. Ironically, periodontal practitioners have 
focused on the bacterial etiology of PD and believed that plaque removalwas 
aimed at eliminating specific bacteria or bacterial complexes. However, it seems 
that the reduction of inflammation and attenuation of the host’s immune reaction 
to the microbial plaque, eventually leading to a decrease in the ratio of 
RANKL/OPG and a decrease in associated bone loss, are the actual and desired 
outcomes of periodontal therapy. 
 
S. R. Goldring (2003)
102
 stated that Inflammatory disorders such as rheumatoid 
arthritis (RA), may have profound effects on skeletal homeostasis. In contrast to 
physiologic remodeling in which mechanical influences and/or systemic endocrine 
hormones initiate the remodeling  process, in disorders such as RA the recruitment 
of macrophage lineage cells to sites of  inflammation and the action of local 
osteoclastogenic cytokines associated with the inflammatory process initiate the 
remodeling process. In both physiologic and pathologic remodeling, osteoclasts 
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appear to be the principal cell type responsible for the bone resorption. In 
addition, many of the same cytokines and mediators are involved in physiologic 
and pathologic bone remodeling. These observations have important implications 
with respect to the development of therapeutic strategies to prevent bone loss in 
inflammatory conditions. 
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                                            MATERIALS AND METHODS 
 
Informed consent was obtained from all the subjects and the study protocol 
was reviewed by the Institutional Review Board (IRB) of Ragas Dental College 
and Hospital, Chennai.  
 
The study group consisted of 10 subjects with the following inclusion 
criteria:  
 
1. Patients with class 1 malocclusion with bidental  protrusion, who has not  
undergone  previous orthodontic treatment.    
2. These subjects, ranged in age from 15 yrs to 25 yrs.  
3. All the patients were treated using .022 Roth Ovation fully programmed 
brackets.  
4. All the subjects were indicated for upper and lower first bicuspid 
extraction.  
5. All subjects were in good general health with healthy periodontal tissues.  
6. Probing depths were < 3mm with no radiographic evidence of periodontal 
bone loss.  
7. All of them were treated by post-graduate students in the Department of 
Orthodontics, Ragas Dental College and Hospital, Chennai.  
 
Subjects were excluded if:  
1. They had antibiotic therapy during the previous six months; or 
2. They had taken anti-inflammatory medication during the month preceding 
the start of the   study.  
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3. Patients with active periodontal problem , Syndromic or reports of allergic 
reaction 
4. Patients who underwent orthodontic treatment before  
 
METHODS 
Gingival crevicular fluid was collected at the following stages:  
T0 – Before initiation of treatment 
T1 -  92  days after  levelling and alignment stage 
 
The samples were collected at T0,T1 from the anterior sextants of the 
maxillary and mandibular arches, amounting to a total of 4 samples per subject. At 
the beginning of treatment, T0 –  GCF samples were collected  from upper and 
lower arches.  All the subjects were bonded with fully programmed .022 Roth 
Ovation brackets following upper and lower first bicuspid extraction. Leveling 
and aligning was carried out through a sequence of arch wires beginning with .014 
Niti and culminating in .019 x .025 SS. Once the stage 1 was completed on an 
average within 92 days from start of leveling & alignment, Samples were 
collected at this point from the anterior sextants of both the arches and were 
labeled as T1. 
 
GCF collection  
 To avoid contamination of the GCF samples, small deposits of plaque 
were removed with a periodontal probe, and heavy deposits with a sickle 
scaler.  
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 Following the isolation and drying of a site, disposable micropipettes 
(Ringcaps® - Hirschmann Labergerate, Hauptstr)  were inserted into the 
entrance of the gingival crevice.  
 4-5μl of GCF was collected from the six anterior teeth in both the 
maxillary and mandibular arches .  
 The collected GCF was stored in sterile Eppendorf tubes  at -65°C.  
 
The collected samples were analysed at Hubert Enviro Care Pvt. Ltd, Chennai  
 
ELISA Testing for  Interleukin - 10 
The collected GCF samples were tested for interleukin – 10 using the Gen-
Probe Diaclone Human IL – 10 ELISA kit (Gen-Probe Diaclone sas, FRANCE). 
The microtiter plate provided in this kit has been pre-coated with an antibody 
specific to IL – 10.  
 
Assay Procedure  
1. Each of the collected samples was diluted using the sample diluents 
provided in the kit.  
2. The diluents used were the Phosphate Buffered Saline (PBS)100μl of 
sample was added per well. The wells were covered with adhesive strips 
and incubated for 15 - 20 hours at 37°C.  
3. The liquid from each well was removed, not washed.  
5. The plate is incubated at 4 0 C for 10 min. 
6. 100ml of diluted detection antibody is added  to every well and incubated 
at room temperature for 1 hour 30 minutes. 
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4. After washing the plate for 3 times 100ml of diluted Streptavidin-AP 
conjugate is added to every well and incubated at room temperature. 
7. 100ml of ready-to-use 5-Bromo-4-Chloro-Indolyl-Phosphatase/ nitroblue 
tetrazolium buffer is added to every well. 
8. Then the plate is incubated for 5-15 min monitoring spot formation 
visually throughout the incubation period to assess sufficient colour 
development. 
9. The frequency of the resulting coloured spots corresponding to the 
cytokine producing cells can be determined using an appropriate ELISpot 
reader. 
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FIGURE 1: MICROPIPETTE FOR GCF COLLECTION 
 
 
       
 
FIGURE 2: EPPENDORF TUBES 
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FIGURE 3:  BEFORE START OF THE TREATMENT (T0) 
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FIGURE 4: END OF STAGE I-LEVELING & ALIGNING (T1) 
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FIGURE 5a: GCF COLLECTION (UPPER ARCH) 
 
 
 
 
 
FIGURE 5b: GCF COLLECTION (LOWER ARCH) 
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FIGURE 6: ELISA PLATE READER 
 
 
 
 
FIGURE 7 :  IL -10 ELISA KIT & REAGENTS 
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RESULTS 
The optical density of the samples was determined using an ELISA plate 
reader (Figure 9). 
 
The concentration of IL – 10 (pg/ml) in the samples was then determined 
by comparing the optical density of the samples to standard curves. Linear 
regression analyses were employed to obtain the standard curves (Figure 10) from 
which the corresponding concentrations of IL – 10 were determined.   
 A Mann – Whitney test was performed.The hypothesis being tested was 
that the concentration of IL – 10 increases in bone remodelling from 
baseline to end of levelling and alignment stage between upper and lower 
arches. 
 Wilcoxon – signed ranks test was performed to compare the mean values 
of concentration of IL – 10 from baseline ( T0 ) to end of levelling and 
alignment stage ( T1). 
 The statistical analysis was carried out in the following parts;  
o Mean IL – 10 values in  upper arch 
o Mean IL – 10 values in  lower arch 
o Mean IL – 10 values in baseline ( T0) 
o Mean IL – 10 values in end of levelling and alignment stage ( T1) 
 
 The level of statistical significance was set at p=0.05.  
 If the value of ‗p‘ > 0.05, then the inference is that there is no statistical 
difference between the variables being compared.  
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 However, if the value of ‗p‘ < 0.05, then the inference is that there is a 
statistical difference between the variables being compared  
 
UPPER ARCH 
The mean IL – 10 value at T0 was 199.7 + 142.3 pg/ml and T1 was 229.5 
+163.2 pg/ml. 
 
A statistically significant increase (p < 0.028) in the IL -10  concentration 
was observed at T1 compared to T0. 
 
LOWER ARCH 
The mean IL – 10 value at T0 was 126 + 172 pg/ml and T1 was 146 + 
196.8 pg/ml. 
 
A ststistically significant increase ( p< 0.041) in the IL – 10 concentration 
was observed at T1 Compared to T0. 
 
According to mann – whitney test no significant statistical differences 
were observed when compared IL – 10 values between upper and lower arches. 
 
Although in Wilcoxon – signed ranks test IL – 10 values increased from 
T0 to T1. 
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OD: OPTICAL DENSITY 
Pg/ml: PICOGRAMS/ MILLILITRE 
 
 
IL-10 STANDARD CURVE 
                                                                                                                                                                                   
STANDARD IL-10 CONC pg/ml Absorbance(450nm) 
1 400 0.961 
2 200 0.5 
3 100 0.25 
4 50 0.14 
5 25 0.06 
6 12.5 0.03 
ZERO 0 0 
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Table 1:   Mann-Whitney Test to compare the mean values between  
Upper and Lower arches 
 
Variables Group N Mean Std. Deviation P-Value 
Time 0 
Upper Arch 6 199.7 142.3 
0.229 
Lower Arch 6 126.0 172.0 
Time 1 
Upper Arch 6 229.5 163.2 
0.374 
Lower Arch 6 146.0 196.8 
Absolute 
Difference 
Upper Arch 6 29.83 30.12 
0.194 
Lower Arch 6 20.00 46.06 
Relative 
Difference 
Upper Arch 6 13.09 10.43 
0.575 
Lower Arch 6 12.26 13.96 
 
Table 2:  Wilcoxon Signed Ranks Test to compare the mean values  
between Time 0 and    Time 1 
 
Variables Group N Mean Std. Deviation P-Value 
Upper Arch 
Time 0 6 199.7 142.3 
0.028 
Time 1 6 229.5 163.2 
Lower Arch 
Time 0 6 126.0 172.0 
0.041 
Time 1 6 146.0 196.8 
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CHART 1: MEAN IL-10 values in upper and lower arch & time variables 
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DISCUSSION 
The study of bone remodeling was introduced in 1892 when German 
surgeon, Julius Wolff, proposed that a transformation of both the internal and 
external bone architecture occurs in response to prolonged stresses acting upon it 
(Frost, 2004). Since that time, Wolff’s Law has been updated, modified, and 
expounded upon as researchers continue to explore the complex field of bone 
biology. At first glance, it may appear that orthodontic tooth movement can be 
explained by simple physics: a force is applied to a tooth until friction is overcome 
and the tooth begins to move. Whereas this may explain the interface between the 
tooth and the orthodontic appliance, it does not address the biological mechanisms 
involved.  
 
Orthodontic tooth movement is a unique phenomenon where a solid object 
moves through a solid medium. Therefore the biological intricacies involved with 
this type of movement are novel and not entirely understood. As orthodontic 
forces are applied, the mechanical loading within the system increases, and a 
complex cascade of biological events lead to the remodeling of the surrounding 
tissues and eventual movement of the tooth (Masella and Meister, 
2006)
111
.understanding of bone remodeling is of particular  interest to the 
profession of orthodontics. 
 
Previously bone resorptive markers were studied extensively using the 
GCF samples from rats.
123 
Other forms of bone remodelling studies have been 
studied using cone beam computed tomography ( cbct) ,but the drawbacks in 
those study were the radiation dosage was a factor of concern to the orthodontic 
 
Discussion 
 
 62 
profession
114
 . So a non-invasive methodology to study bone remodelling in 
patients have to be studied in this regard so the GCF study was undertaken. 
 
Although studies have been done in the past using different markers , very 
few studies have been done using IL – 10 marker. So the present study was done 
to quantify bone remodelling based on IL – 10. Prior to this study many studies 
based on orthodontic tooth movement evaluation using gcf was carried out in 
subjects who were in retraction stage or end of retraction stage. In those studies 
bone remodelling was identified with elevation of the pro-inflammatory and anti – 
inflammatory markers.  
 
In this study we are assessing bone remodelling at the end of levelling and 
alignment stage itself by quantifying the elevation of IL – 10 marker between the 
two time points T0 and T1 and between upper and lower arches which is unique to 
this study. Leveling and alignment is the first stage of an orthodontic treatment 
sequence. During this stage, a flexible archwire usually a nickel titanium (NiTi) 
wire was tied into the bracket slot.  
 
The NiTi archwire exerts a light continuous force between 30 and 60 g 
onto the teeth in order to level and align the dentition. A tipping movement is 
produced through combination of bracket-archwire system in a fixed orthodontic 
appliance. Consequently, tooth will tend to rotate around its centre of resistance 
compressing the periodontal ligaments near the apex of the root on the same side 
of the force applied. On the other side, PDL around the crest of alveolar bone will 
be compressed. 
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This insight into the bone remodelling at the levelling and alignment stage 
itself will provide in depth knowledge of the bone remodelling mechanism itself 
in initial stages of tooth movement. 
 
IL-10 PRODUCTION  
Interleukin (IL)-10 is a cytokine that modulates both innate and adaptive 
immunity, primarily by exerting anti inflammatory effects
117
. IL-10 was originally 
thought to be produced only by T helper (Th)2 cells, but is now known to be made 
by a variety of cell types. During many infections, CD4+ T cells produce both 
interferon (IFN)-γ, the signature Th1 cytokine, and IL-10. New data now show 
that the IL-10 produced by effector Th1 cells helps limit the collateral damage 
caused by exaggerated inflammation. But this control may also limit the 
effectiveness of the immune response, resulting in a failure to fully eliminate 
pathogens.  
IL-10 is also made by CD4+ Foxp3+ CD25+ “natural” regulatory T (T 
reg) cells and IL-10–induced CD4+ T reg cells (Tr1 cells).  
 
IL – 10 AND OSTEOCLASTS 
Osteoclasts are terminally differentiated multinuclear cells derived from 
monocyte macrophage lineage cells and are responsible for bone resorption
125
. 
OC-like cells, produced in vitro by coculturing mouse bone marrow cells and 
primary osteoblastic cells (POBs) in the presence of osteotropic hormones(1) 
exhibit many of the characteristics of authentic OCs including tartrate-resistant 
acid phosphatase (TRAP) activity, abundant calcitonin (CT) receptors, and the 
ability to form resorption lacunae on dentine slices.(2) The differentiation and 
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function of OCs are regulated tightly by hormones, in particular, calcium 
regulating hormones such as parathyroid hormone (PTH) and 1,25- 
dihyroxyvitamin D3[1,25(OH)2D3], as well as cytokines such as interleukin-1 
(IL-1), tumor necrosis factor a (TNFa), and the IL-6 family.  
 
In a study by hong et al reveals that IL-10 inhibits osteoclastogenesis by 
directly targeting bone marrow– derived mononuclear cells (BMM), which  have 
been recognized as the origin of OC precursor cells, through a receptor and 
signaling pathway specific for IL-10. First, IL-10 inhibits IL-6 production by 
BMM but not by osteoblasts. Second,STAT 1–like molecules were activated by 
IL-10 only in the treatment of BMM with IL-10 did not alter the protein profile. 
Interestingly, a 70-kDa phosphoprotein also was reported previously in peripheral  
monocytes and treated with IL-10 and this protein was recognized by an antibody 
to STAT 3.  
 
O’Farrell et al. also reported that IL-10 inhibited macrophage proliferation 
through the STAT 3–dependent pathway. However, we found that the 70-kDa 
phosphoprotein activated by IL-10 in BMM was recognized by an antibody to 
STAT 1 but not by an antibody to STAT 3. Therefore, different STAT(s) may be 
activated by IL-10 in BMM and peripheral monocytes. This finding suggests that 
IL-10 may activate STAT like proteins other than STAT 1 and STAT 3 such as 
88, 85, and 70 kDa proteins in the BMM cells. These STAT-like proteins remain 
to be identified. IL-6 also has shown a strong activity in OC formation in vitro in 
the presence of soluble IL-6  receptor(29) and in response to dexamethasone that 
induces IL-6 receptor production in osteoblasts.(30) However, the inhibitory 
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effect of IL-10 on OC formation is unlikely to becaused by inhibition of IL-6 
production. First, osteoblast derived IL-6 production was 10 times greater than 
that derived from BMM cells, and IL-10 did not inhibit IL-6 production by the 
POB while it decreased by 50% the IL-6 production by BMM cells. Second, IL-6 
alone was unable to promote osteoclastogenesis in this mouse coculture system 
without the supplement of soluble IL-6 receptor. 
 
Recently, molecular cloning technique appears to give an insight into the 
understanding of the mechanism of osteoclastogenesis. TRANCE/ RANKL/ 
OPGL/ ODF stimulated by bone resorbing agents such as 1,25(OH)2D3, PTH, 
and IL-11 family in osteoblastic cells interacts with its receptor molecule, namely, 
RANK, which is a TNF-a receptor family on the surface of OC precursor cells. 
Importantly, TRANCE/RANKL/OPGL/ODF knockout mice showed severe 
osteopetrosis and a combination of OPGL/ODF and M-CSF are sufficient for OC  
Formation in vitro in the absence of osteoblasts, suggesting that the 
TRANCE/RANKL/OPGL/ODF is the crucial factor for osteoclastogenesis. 
Furthermore, NF-kB1 and NF-kB2 double-knockout mice developed osteopetrosis 
because of a defect of OC differentiation. Because NF-kB is the key component of 
the RANK signal pathway, NF-kB plays a central role in response to bone 
resorbing agents in the differentiation and functions of OC. Taken together, these 
pieces of evidence support the notion that TRANCE/RANKL/OPGL/ODF and M-
CFS signal pathways are essential for osteoclastogenesis. 
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They concluded that we found that the inhibitory effect of IL-10 on OC 
formation is mediated through OC precursor cells and that novel STAT 1–like 
proteins may be involved in this inhibitory effect. 
 
IL – 10 AND BONE RESORPTION 
Whether bone loss will occur in response to an inflammatory reaction is 
now known to depend on two critical factors
118
. First, the concentration of 
inflammatory mediators present in gingival tissue must be sufficient to activate 
pathways leading to bone resorption. Second, the inflammatory mediators must 
penetrate gingival tissue to reach within a critical distance to alveolar bone. 
Achieving critical concentrations of inflammatory mediators that lead to bone 
resorption depends on the expression of proinflammatory cytokines, such as 
interleukin (IL)-1, -6, -11, and -17, tumor necrosis factor-alpha (TNF-a), leukemia 
inhibitory factor, and oncostatin M. The kinins, such as bradykinin and kallidin, 
and thrombin and various chemokines also have a stimulatory effect on bone 
resorption.8 This is the opposite of the expression of anti-inflammatory cytokines 
and other mediators, such as IL-4, -10, -12, -13, and -18, as well as interferon-beta 
(IFN-b) and -gamma (IFN-g), which serve to inhibit bone resorption. 
 
During an inflammatory response, cytokines, chemokines, and other 
mediators stimulate periosteal osteoblasts, altering expression levels of a protein 
called receptor activator of nuclear factor-kappa B ligand (RANKL) on the 
osteoblast surface. RANKL is expressed by osteoblasts in a membrane-bound 
protein or cleaved into a soluble form. In addition to osteoblasts, RANKL is 
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expressed by a number of other cell types, including fibroblasts and T and B 
lymphocytes. 
 
THE RANKL–RANK–OPG AXIS 
Under normal physiologic conditions, there is a balance between bone 
resorption and bone formation.10This balance promotes bone homeostasis, 
including the maintenance of structural integrity and calcium metabolism.6 In 
certain inflammatory bone conditions, the balance is altered such that bone 
formation is enhanced, as in osteopetrosis, or excessive bone resorption occurs, 
such as that observed in osteoporosis and periodontitis. Accordingly, excessive 
formation of bone may be attributed to an abundance of OPG or reduced 
expression of RANKL, resulting in a net increase in OPG, also known as a 
decrease in the RANKL/OPG ratio . Conversely, a relative decrease in 
concentrations of OPG or increase in RANKL expression may result in a net 
increase in RANKL and pathologic bone resorption, also known as an increase in 
the RANKL/OPG ratio. During an inflammatory response, proinflammatory 
cytokines, such as IL-1b, -6, -11, and -17 and TNF-a, can induce 
osteoclastogenesis by increasing the expression of RANKL while decreasing OPG 
production in osteoblasts/stromal cells. In contrast, anti-inflammatory mediators, 
such as IL-13 and IFN-g, may lower RANKL expression and/or increase OPG 
expression to inhibit osteoclastogenesis. 
 
IL-10 AND BONE REMODELLING 
The structural elements and matrix components of the skeleton are 
remodelled throughout life. This process is accomplished by the actions of a 
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complex multi-lineage cellular system involving hematopoietic (osteoclasts) and 
mesenchymal (osteoblasts) cells
102
.  
 
There remains controversy, however, regarding the evolutionary basis and 
principal functional role of bone remodeling. For example, it has been suggested 
that remodeling has evolved as a system that permits adaptation of skeletal 
architecture to changing mechanical environments. Remodeling also provides a 
mechanism for repair of bone micro-damage sustained during repetitive 
mechanical loading a process that would impart a distinct selective evolutionary 
advantage. Finally, it has been suggested that remodeling has evolved as a system 
for regulating mineral ion homeostasis.  
 
These distinct functional roles of bone remodeling are not necessarily 
exclusive, and under physiologic or certain pathologic conditions each of these 
mechanisms may provide the major adaptive drive for recruitment of the cellular 
elements required for initiation and completion of the remodeling cycle. 
Differential regulatory systems are involved, depending upon whether bone 
remodeling is generalized or localized to specific skeletal sites. Generalized 
remodelling characteristically is initiated by systemic hormones such as 
parathyroid hormone (PTH). This form of remodelling has been classified as non-
targeted since it affects the entire skeleton, although even in this situation there 
may be preferential involvement of anatomic sites. In contrast, so-called ‘‘targeted 
remodeling’’ is restricted to distinct skeletal sites. Micro-cracks in the bone matrix 
and/or high local deformation around osteocytic lacunae have been suggested as 
potential signals for initiation of this form of remodelling. 
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IL – 10 IN PERIODONTICS 
Anti-inflammatory cytokines, such as IL-10, are widely expressed in 
diseased periodontal tissues and are associated with lower disease severity. 
Indeed, IL-10 presents a protective role toward tissue destruction, inhibiting both 
MMPs and RANK systems. IL-10 characteristically induces the up-regulation of a 
group of endogenous proteins named tissue inhibitors of metalloproteinases 
(TIMPs), which are capable of inhibiting almost every member of the MMP 
family in a nonspecific way. In addition, IL-10 stimulates the production of OPG, 
a decoy receptor of RANKL, which strongly inhibits bone resorption by 
preventing RANK-RANKL engagement. In agreement, a positive correlation 
between the levels of IL-10, TIMPs, and OPG was demonstrated in both human 
and experimental periodontal diseases. 
 
Gingival Crevicular Fluid 
GCF represents a powerful fluid vehicle for the diagnostic clinician since 
it contains, depending upon the clinical situation an array of biochemical and 
cellular factors, which feature as biomarkers of the state of the periodontium.The 
early work of Embery et al. (1982), Last et al. (1985), and Waddington et al. 
(1994) have described the appearance and identification of a range of 
glycosaminoglycan, proteoglycan and tissue glycoproteins, which provide 
biochemical evidence on the underlying state of the biochemical tissues, which 
elude normal clinical parameters. GCF can variously be described as a transudate 
or an exudate. It is a fluid that arises at the gingival margin and can be collected 
by a variety of procedures providing noninvasive, site-specific process. Its 
collection requires patience on the part of the clinician and ranges from the use of 
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platinum loops, filter-paper strips, gingival washings, and the use of 
micropipettes, favoured by ourselves. The advantage of the latter procedure is 
ready storage, quantitation and application for either electrophoresis of direct 
chemical assessment. 
The outcomes of a number of studies indicate that GCF is a feature of the 
fine nature of the gingival vasculature where the effect of trauma to the 
permeability of the arterial and venular capillaries leads to fluid production 
(Figure 3). In periodontal disease there is an increase in GCF volume, which 
clearly arises by breaching of the normal integrity conferred by the basement 
membrane and junctional epithelia. It has been established that this process is 
accompanied by enlargement of the intercellular spaces of the junctional 
epithelium and partial destruction of the basement membrane (Freedman et al., 
1968). Such events will lead to the production of a semi-permeable membrane and 
an osmotic gradient (Alfono, 1974).  
 
This will draw interstitial fluid from the surrounding capillaries and 
lymphatic system. The initial exudate is usually discarded, since it is not defined 
as an inflammatory exudate. However, with time a secondary inflammatory 
exudate, defined as GCF is evident and provides the basis for identification of 
constituent biomarkers, which represent the metabolic state of the underlying and 
deeper-seated tissues of the periodontium. 
 
The value of GCF in the assessment of orthodontic movement will be 
governed by different parameters as essentially it will be non-inflammatory and 
non-plaque influenced. The resorptive/synthetic trauma on the deeperseated 
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tissues of the periodontium will induce a fluid pressure flow, which may be used 
to assess factors influencing orthodontic assessment. Evidence will be presented 
later to show that movement of alveolar bone and periodontal ligament induces 
the production of extracellular matrix factors for use as biomarkers of orthodontic 
treatment. 
 
ELISA : The enzyme-linked immunosorbent assay (ELISA) is an important 
tool in for detecting the presence of an antibody or an antigen in a sample. The 
ELISA's key features are its high level of sensitivity and robustness. It allows easy 
visualization of results and can be completed without using any radioactive 
materials because of which it remains a desired assay of choice for routine 
scientific, medical and veterinary diagnostic assays. 
Types of ELISA : There are two basic types known of ELISA: 
1) Indirect ELISA : This method is used to determine the presence of a specific 
antibody in a given specimen. The steps of the general, indirect, ELISA for 
determining serum antibody concentrations are:    
1) The sample containing a known antigen of defined concentration is added 
to the well of a microtiter plate where it adsorbs to the wells of the plate 
through charge interactions.   
2) A concentrated solution of non-interacting proteins, such as Bovine Serum 
Albumin (BSA) or casein, is added to the plate wells to block the non-
specific adsorption.   
3) Test-antiserum is added to these walls and allowed to incubate; if the 
antibodies in test antiserum are homologous, they bind with adsorbed 
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antigens forming antigen-antibody complex. The wells are again washed to 
remove any free antibodies. 
4) Enzyme-conjugated (labelled) antibodies are now added which link to the 
antigen-antibody-complex formed in the previous step.   
5) The plate is washed again to remove excess unbound enzyme-antibody 
conjugates.   
6) A chromogenic substrate is applied which converts the enzyme to elicit a 
signal.  
7) The result is viewed/quantified using a spectrophotometer. 
 
2) Direct ELISA : This method employs monoclonal antibodies for detection of a 
particular  antigen in a sample.In this approach, the steps involved are as follows : 
1) An unlabeled antibody specific to the antigen of interest is immobilized in 
microtiter well.  
2) The antigen is added and allowed to react with the immobilized antibody 
to form Ag-Ab complex. 
3) An Enzyme conjugate is added (that is specific to the antigen) which forms 
a double antibody sandwhich  
4) The unreacted antibodies are washed away. Thereby, enzyme subsrate is 
added to elicit a chromogenic or fluorogenic signal. 
5) Results are quantified using a spectrophotometer, spectrofluorometer, or 
other optical device. This procedure is also referred to as, Double 
Antibody Sandwitch (DAS) ELISA. 
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Advantages and disadvantages of both Direct and Indirect ELISA : 
A. Advantages of using direct ELISA : It is relatively quick as only one 
antibody is used. Hence, fewer steps are involved. Also, cross-reactivity of 
secondary antibody is eliminated. 
B. Disadvantages of using direct ELISA : By labeling the primary antibody 
with enzymes, its Immunoreactivity might be affected. Also the labeling 
for every specific ELISA is time-consuming and a costly affair. Moreover, 
this method gives minimum signal amplification compared to indirect 
method. 
C. Advantages of using indirect ELISA : Plenty of commercially available 
labelled secondary antibodies are available. This method generates a 
stronger signal amplification. Also, many different visualization markers 
can be used with the same primary antibody. 
D. Disadvantages of using indirect ELISA: There are chances of cross-
reactivity with the secondary antibody which may give non-specific 
signals. Also, steps are increased in this method. In the present study, we 
found increased levels of INTERLLEUKIN - 10 in GCF samples collected 
from areas adjacent to teeth undergoing orthodontic tooth movement. In 
both the upper and lower arches the increase in IL - 10 levels was found to 
be statistically non-significant when compared between the arches but 
statistically significant when comparing between the baseline (T0) and at 
the end of levelling and alignment stage (T1).(Table 1 & 2). 
 
The IL – 10 levels increased from   T0 at 199.7 pg/ml  to  T1 at  229.5  
pg/ml (p<0.028) for the  
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Upper arch and T0 at 126  pg/ml and T1 was 146  pg/ml (p<0.041) .(figure 4). 
 
These values enable us to interpret and calculate the relative INTERLEUKIN 
- 10 which is a major determinant in bone remodeling during orthodontic tooth 
movement. 
 
Formation of bone may be attributed to an abundance of INTERLEUKIN–10. 
 
In the present study an increase in interleukin – 10 was recorded in both the 
arches which indicates a definite shift towards osteoblastic activity . ( Table 1 & 2) 
 
Available literature amply implicates an increase in the  INTERLEUKIN – 10  
in the progression of periodontal disease and in bone remodeling during orthodontic 
tooth literature. However, the factors contributing to this increase in ratio may vary. 
 
The detection of local concentration of INTERLEUKIN – 10 in GCF and with 
levelling and alignment stage force application can help the orthodontist to assess the 
status of bone remodeling during tooth movement. The concentration of 
INTERLEUKIN – 10 may change with the intensity of orthodontic forces. The 
orthodontist may use this information as a guide for detecting the optimum 
orthodontic treatment duration to avoid pathologic alveolar bone and root resorption 
and hyalinization in patients with bone metabolism pathologies such as 
hypoparathyrodism or hyperparathyroidism and also in patients with inflammatory 
conditions like periodontitis. At present, there may be many questions about the local 
response of the bone to the orthodontic forces. In the future, further research and 
refinement in this field may help to clear this ambiguity.  
 
Summary and Conclusion 
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SUMMARY AND CONCLUSION 
 
This study was undertaken to assess the change in INTERLEUKIN – 10  
levels in the GCF following the application of orthodontic force. GCF samples 
were collected from the upper and lower arches of orthodontic patients who had 
undergone upper and lower first bicuspid extractions. The samples were collected 
at two time points; T0- before treatment and T1- at the end of levelling and 
alignment stage. Disposable micropipettes (5ul) were used for GCF collection and 
the collected samples were subjected to an ELISA test to determine the 
concentrations of INTERLEUKIN - 10. 
 
Both the upper and lower arches showed an increase in concentration of IL -10 
 The mean IL – 10 value at T0 was 199.7 + 142.3 pg/ml and T1 was 229.5 + 
163.2 pg/ml. A statistically significant increase (p < 0.028) in the IL -10 
concentration was observed at T1 compared to T0 in the upper arch. 
 The mean IL – 10 value at T0 was 126 + 172 pg/ml and T1 was 146 + 196.8 
pg/ml. A statistically significant increase (p< 0.041) in the IL – 10 
concentration was observed at T1 Compared to T0 in the lower arch. 
 The study shows a variation in IL – 10 from T0 to T1 quantifying bone 
formation at the end of levelling and alignment stage itself. Further research 
in this field would help to refine the analysis of these biologic markers of 
tooth movement in a clinical setting. This sort of advancement would be 
especially useful in patients with bone metabolic problems as well as in 
patients suffering from inflammatory periodontal disease.  
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